HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.

AbstractBACKGROUND AND OBJECTIVES:
Minor histocompatibility antigen (mHag)-specific graft-versus-leukemia reactivities are observed following unselected donor lymphocyte infusion for the treatment of relapse after HLA-matched mHag-mismatched stem cell transplantation (SCT). Adoptive transfer of donor-derived ex vivo-generated HA-1-specific oligoclonal T cells or HA-1 peptide patient vaccination are currently being explored as curative tools for stem cell based immunotherapy of hematologic malignancies. Another treatment modality to eradicate residual leukemic cells after SCT is the transfer of the HA-1 hematopoietic-specific T-cell receptor (TCR) into cells from the stem cell donor. This strategy would be particularly useful in case of relapse after cord blood transplantation (CBT) and is explored in this study.
DESIGN AND METHODS:
HLA-A2(neg) adult peripheral blood and cord blood mononuclear cells were transduced with the genes encoding the HA-1 alpha and beta TCR chains derived from established HA-1 specific cytotoxic T lymphocyte clones.
RESULTS:
The T cells transduced with HA-1 TCR alpha beta showed consistent marker gene expression, but low staining with HLA-A2/HA-1 tetrameric complexes. They did, however, show hematopoietic-restricted cytolytic activity against HLA-A2(pos)/HA-1(pos) target cells, including leukemic cells.
INTERPRETATION AND CONCLUSIONS:
The low level of HA-1-specific tetramer staining of HA-1 TCR alpha beta transduced T cells may be caused by hybrid TCR formation of the transferred TCRalpha and beta chains with endogenous TCR alpha and beta chains. This may cause unwanted alloreactivity and requires attention. The HA-1 TCR alpha beta transduced T cells show that the HA-1 TCR can be functionally transferred into donor mononuclear cells, which can be exploited in immunotherapeutic settings of SCT and CBT for hematologic malignancies.
AuthorsBregje Mommaas, Astrid G S van Halteren, Jos Pool, Lars van der Veken, Brigitte Wieles, Mirjam H M Heemskerk, Els Goulmy
JournalHaematologica (Haematologica) Vol. 90 Issue 10 Pg. 1415-21 (Oct 2005) ISSN: 1592-8721 [Electronic] Italy
PMID16219579 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Epitopes, T-Lymphocyte
  • HA-1 antigen
  • Minor Histocompatibility Antigens
  • Oligopeptides
  • Receptors, Antigen, T-Cell
Topics
  • Adult
  • Epitopes, T-Lymphocyte (administration & dosage, genetics)
  • Fetal Blood (immunology)
  • Gene Transfer Techniques
  • Humans
  • Jurkat Cells
  • Minor Histocompatibility Antigens (administration & dosage, genetics, immunology)
  • Oligopeptides (administration & dosage, genetics, immunology)
  • Receptors, Antigen, T-Cell (administration & dosage, genetics)
  • T-Lymphocyte Subsets (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: